<DOC>
	<DOC>NCT01795352</DOC>
	<brief_summary>This is a national, multicentre, non-interventional, retrospective study to be carried out in the oncology settings of approximately 15-20 Spanish hospitals. At each participant hospital, all patients recently diagnosed with advanced EGFR mutated NSCLC (both newly or with recurrent disease , without previous treatment for metastatic disease) from April 2010 to December 2011 will be included as study population. Information about the follow-up of the patients during a minimum of 12 months after diagnosis will be collected.</brief_summary>
	<brief_title>Retrospective Study in a NSCLC M+ p</brief_title>
	<detailed_description>Observational retrospective study to describe the management of advanced or metastatic EGFR mutated non-small cell lung cancer patients in Spain</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<criteria>Histologically or cytologically confirmed newly locally advanced or metastatic NSCLC (stage IIIB/IV) Confirmed EGFR mutation by a validated test Availability of medical record Participating on a blinded randomized clinical trial at any time during the study period Pregnant women (due to they do not reflect daily clinical practice)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>EGFR,</keyword>
	<keyword>lung cancer,</keyword>
	<keyword>mutated</keyword>
</DOC>